PharmiWeb Today Story
- Generative modelling artificial intelligence (AI) technology will be used to optimise advanced compounds, to speed up the identification of promising drug candidates for an undisclosed Almirall drug discovery program.
- This tackles one of the key challenges in drug design: rapid identification of molecules which simultaneously satisfy multiple bioactivity and drug-like criteria for clinical testing.
- Through this collaboration, Almirall will leverage Iktos’s AI precision and agility to truly make a difference in patients' lives.
Almirall, S.A. (ALM), a leading skin-health focused global pharmaceutical company, and Iktos, a company specialized in Artificial Intelligence for novel drug design, today announced a collaboration agreement in Artificial Intelligence (AI) , where Iktos generative modelling AI technology will be used to design novel optimized compounds, to speed up the identification of promising drug candidates for an undisclosed Almirall drug discovery program(s).
Iktos’ AI technology, based on deep generative models, helps bring speed and efficiency to the drug discovery process, by automatically designing virtual novel molecules that have the desirable characteristics of a novel drug candidate. This tackles one of the key challenges in drug design: rapid and iterative identification of molecules which simultaneously validate multiple bioactive attributes and drug-like criteria for clinical testing.
“This partnership is an example of how we intend to explore the enormous possibilities offered by technology to find new molecules and to speed up clinical developmen…Read More...
All about the box
IDMP: delivering patient benefits – what next?
J42 Clinical Trial Administration - Beyond the Bas…
25-Nov-2020 - 25-Nov-2020
J41 The Proactive Clinical Researcher
24-Nov-2020 - 24-Nov-2020
J40 Essentials of Clinical Trial Monitoring
19-Nov-2020 - 19-Nov-2020
J38 Statistics for Non-Statisticians
17-Nov-2020 - 17-Nov-2020
J37 Effective Project Management for Clinical Tria…
10-Nov-2020 - 12-Nov-2020
The Economics of Public Health
04-Nov-2020 - 04-Nov-2020
ADMS LOSS NOTICE ALERT: TOP RANKED Rosen Law Firm…
FDA approves use of drug to reduce risk of cardiov…
PTC Therapeutics Reports Inducement Grants Under N…
FDA clears first fully disposable duodenoscope, el…
FDA authorizes first interoperable, automated insu…
Gel Stent Market Outlook, Segments Share Analysis,…